David Allen
Dermatology · Ogden, UTNPI 1487672986
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.0%), consulting fees and education — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Boehringer Ingelheim at 46.8% of the total. Reporting peaked in 2023 at $3,030 and has fallen 81.5% since, to $560 in 2025.
Across 168 payments — averaging $31.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$3K
- Novartis$858
- AbbVie$610
- Johnson & Johnson$250
- Sanofi$233
- E.r. Squibb & Sons, L.L.C.$165
- plus $723 from 15 others
What the payments were for
- Consulting fees$2,50047%
- Food & beverage$2,72451%
- Education$1142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 1 | $2,500 |
| Novartis | 60 | $858 |
| AbbVie | 39 | $610 |
| Johnson & Johnson | 7 | $250 |
| Sanofi | 13 | $233 |
| E.r. Squibb & Sons, L.L.C. | 10 | $165 |
| Pfizer | 7 | $111 |
| LEO Pharma Inc. | 5 | $102 |
| Dermavant Sciences, Inc. | 4 | $92 |
| Krystal Biotech Inc | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Galderma Laboratories, L.p. | 3 | $56 |
| Lilly USA, LLC | 3 | $48 |
| Genentech USA, Inc. | 3 | $38 |
| Amgen | 1 | $29 |
| Almirall LLC | 1 | $27 |
| Journey Medical Corporation | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $16 |
| Organon | 1 | $15 |
| UCB, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPEVIGO$2,500
How this compares
$5,339 in reported general payments places this provider in the 80th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 18 | $157,990 |
| Dupixent PenDupilumab | 16 | $69,331 |
| Fluorouracil | 129 | $10,559 |
| Fluocinonide | 99 | $5,040 |
| Clobetasol Propionate | 67 | $5,027 |
| Triamcinolone Acetonide | 407 | $4,783 |
| Desonide | 69 | $4,024 |
| Clindamycin Phosphate | 122 | $3,860 |
| Ketoconazole | 210 | $3,286 |
| Metronidazole | 66 | $3,230 |
| Doxycycline Hyclate | 19 | $3,180 |
| Tacrolimus | 14 | $1,355 |
| Econazole Nitrate | 38 | $1,271 |
| Hydroxychloroquine Sulfate | 33 | $1,183 |
| Halobetasol Propionate | 13 | $998 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Ogden
- Chad TingeyOgden$5K
- Adam TaintorOgden$4K
- Brian WilliamsMidvale$876K
- Travis JamesProvidence$437K
- Jason HadleyBountiful$294K
- Doug Lass ForshaWest Jordan$213K
- Gerald KruegerSalt Lake City$156K
- Jamie RhoadsMurray$105K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.